Ishares Healthcare Providers Etf Price To Sales
| IHF Etf | USD 47.81 1.11 2.27% |
iShares Healthcare Providers fundamentals help investors to digest information that contributes to IShares Healthcare's financial success or failures. It also enables traders to predict the movement of IShares Etf. The fundamental analysis module provides a way to measure IShares Healthcare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to IShares Healthcare etf.
IShares |
iShares Healthcare Providers ETF Price To Sales Analysis
IShares Healthcare's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current IShares Healthcare Price To Sales | 0.53 X |
Most of IShares Healthcare's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, iShares Healthcare Providers is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
IShares Healthcare Price To Sales Component Assessment
Based on the latest financial disclosure, iShares Healthcare Providers has a Price To Sales of 0.53 times. This is 82.76% higher than that of the iShares family and 79.96% lower than that of the Health category. The price to sales for all United States etfs is 60.61% lower than that of the firm.
IShares Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses IShares Healthcare's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the etfs which would be a good addition to a portfolio. Peer analysis of IShares Healthcare could also be used in its relative valuation, which is a method of valuing IShares Healthcare by comparing valuation metrics of similar companies.IShares Healthcare is currently under evaluation in price to sales as compared to similar ETFs.
Fund Asset Allocation for IShares Healthcare
The fund invests 100.02% of asset under management in tradable equity instruments, with the rest of investments concentrated in .Asset allocation divides IShares Healthcare's investment portfolio among different asset categories to balance risk and reward by investing in a diversified mix of instruments that align with the investor's goals, risk tolerance, and time horizon. Mutual funds, which pool money from multiple investors to buy a diversified portfolio of securities, use asset allocation strategies to manage the risk and return of their portfolios.
Mutual funds allocate their assets by investing in a diversified portfolio of securities, such as stocks, bonds, cryptocurrencies and cash. The specific mix of these securities is determined by the fund's investment objective and strategy. For example, a stock mutual fund may invest primarily in equities, while a bond mutual fund may invest mainly in fixed-income securities. The fund's manager, responsible for making investment decisions, will buy and sell securities in the fund's portfolio as market conditions and the fund's objectives change.
IShares Fundamentals
| Price To Earning | 19.58 X | |||
| Price To Book | 2.09 X | |||
| Price To Sales | 0.53 X | |||
| Number Of Employees | 56 | |||
| Beta | 0.68 | |||
| Total Asset | 1.51 B | |||
| One Year Return | (4.70) % | |||
| Three Year Return | (2.50) % | |||
| Five Year Return | 5.90 % | |||
| Ten Year Return | 9.00 % | |||
| Net Asset | 1.51 B | |||
| Last Dividend Paid | 0.17 | |||
| Equity Positions Weight | 100.02 % |
About IShares Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze iShares Healthcare Providers's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of IShares Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of iShares Healthcare Providers based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether iShares Healthcare is a strong investment it is important to analyze IShares Healthcare's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact IShares Healthcare's future performance. For an informed investment choice regarding IShares Etf, refer to the following important reports:Check out IShares Healthcare Piotroski F Score and IShares Healthcare Altman Z Score analysis. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
The market value of iShares Healthcare is measured differently than its book value, which is the value of IShares that is recorded on the company's balance sheet. Investors also form their own opinion of IShares Healthcare's value that differs from its market value or its book value, called intrinsic value, which is IShares Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IShares Healthcare's market value can be influenced by many factors that don't directly affect IShares Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IShares Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if IShares Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IShares Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.